AOD9604 is a synthetic peptide derived from the C-terminal fragment (176191) of human growth hormone (hGH), modified to enhance stability and preserve specific metabolic properties while minimizing broader growth hormonerelated effects
That means a 5mg sublingual dose might deliver the equivalent of 0.005mg to the bloodstream, a dose so small it may produce no meaningful physiological effect whatsoever
The next studies revealed particular relationships with sphincter function [197], free-radical-induced injuries [197], bleeding [144,187,192], non-specific and specific NSAID-induced lesions [201], general anesthesia (thiopental) [202] and local anesthesia (lidocaine) [203] induced disturbances, and rat models that resemble schizophrenia-positive symptoms and negative symptoms [171,200]
You can see exactly what you're getting per capsule, which means you can compare the dosage directly against amounts referenced in published preclinical research
For CY 2026, consistent with our established policy, we proposed in the CY 2026 OPPS/ASC proposed rule (90 FR 33533) that the HCPCS codes that would be effective October 1, 2025, would be flagged with comment indicator N1 in Addendum B to the CY 2026 OPPS/ASC final rule with comment period to indicate that we have assigned the codes to interim OPPS status indicators for CY 2026
Research context Research context Intended for non-clinical laboratory studies, 5-Amino-1MQ is used to probe NAD biosynthesis, sirtuin/PARP-linked processes, and related metabolic signaling in cell-based and biochemical assays
